Wednesday, March 31, 2021

Free Webinar on the Global API Market & CDMOs

CPhI & P-MEC China E-trade Season 2021- Your Online Learning and Trading Opportunities for Pharmaceutical Industry
 Free Webinar Session
April 15
16:00 - 17:00
(GMT+8 China Time)
English
Trends in Global API Manufacturing
The global market for the outlook and manufacture of APIs is shifting as more complex or potent ingredients evolve which present specific handling and manufacturing challenges. What are the latest technological approaches for these products, and how can quality, safety and cost be managed and improved upon? A key impact of the COVID-19 pandemic has been to question the reliance and dependence on Asia as the global leader of API manufacturing. Do we expect to see specific regions implement reshoring of manufacturing efforts? How will global supply chains be impacted? Join us as we tackle key trends and dynamics of the API manufacturing sector in just 60 minutes.
What You Will Learn
  • Understand the API manufacturing landscape and key sector trends
  • See how the COVID-19 pandemic has impacted API manufacturing globally
  • Learn about the realities of shifting manufacturing hubs and reshoring manufacturing
  • Hear predictions on what the future of API manufacturing looks like
  • Get an overview of deal making and M&A
Meet the Speakers
Stuart E. Needleman
Chief Commercial Officer, Piramal Pharma Solutions
Gianluca Franguelli
Vice President of Drug Development, Recipharm
Molly Bowman
Editorial Director at Clarivate Analytics
About CPhI & P-MEC E-Trade Season
CPhI & P-MEC China launches the “E-Trade Season” from March - June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. This includes months of informative content and a targeted matchmaking service - delivering over 8 themed webinar series and showcasing high-quality pharma suppliers from 4 popular themes.

Webinars will be offered in Chinese to the Chinese audience and English to the international audience, with bilingual interpretation available. Themes will cover: global pharma trends, pharma APIs supply chain, drug manufacturing and R&D, biopharmaceuticals, quality management, production technology and machinery, pharma packaging & delivery, vitamins market and more! All webinars are free to attend for anyone registered.
Download Calendar &
 Sponsorship Opportunities
CPhI & P-MEC China E-trade Season
March - June 2021

Tuesday, March 30, 2021

PharmaSources E-Newsletter March 2021 Issue 2

Latest News, Products and Events
View this e-mail online
E-Newsletter
March 2021
Editor's Pick
COVID-19 Pandemic has Accelerated Global Vitamin D Market Growth
Amid the excitement of vaccine approvals and roll outs, you can’t have missed the news that vitamin D might help to reduce COVID severity, and might even prevent it. 
More Industry Insights
Hot Products
(S)-4-phenyl-2-oxazolidinone intermediates 
(S)-Methyl Oxazaborolidine intermediates 
Methyl 3-amino-4-methylthiophene-2-carboxylate s
Air conditioning unit 2
 
BXZRH series touch screen emulsifying machine
TURBO T8/16/30/40/60
 
We Want You!
Become a Pharma Product Writer for PharmaSources.com to Reach the Right Audience
Customer Service
(+86) 400 610 1188
PharmaSources@imsinoexpo.com

Monday, March 29, 2021

Biologics R&D and Drug Delivery System

CPhI & P-MEC China E-trade Season
 Free Webinar Session
Biologics R&D and Drug Delivery System
March 30
19:00 - 19:45
(GMT+8 China Time)
English & Chinese
Compatibility Research of Drug and Packaging
Cheng Xiao Zhen
Extractables & Leachables,
Manager, Baxter Healthcare
What you will learn
  • The latest regulations and requirements for extractables and leachables
  • Compatibility research of components used in biopharmaceutical manufacturing
  • Case study: Component compatibility in drug production
March 30
19:45 - 21:00
(GMT+8 China Time)
English & Chinese
Interchangeability Guidelines for Your Biosimilar Product
—— A Pathway for Containment & Delivery Systems
Sponsored by
What you will learn
  • Review the FDA's final guidance of "Considerations in Demonstrating Interchangeability with a Reference Product" released in May 2019.
  • The guidance includes specific requirements with respect to the "Presentation" meaning the containment and delivery systems for the biosimilar.  
  • Analytical Testing Considerations for Biosimilars and Interchangeability. 
Meet the Speakers
Whitney Winters
Senior Director, Strategic Marketing West Biologics, 
Container Systems 
Janet Gaboury
Senior Specialist in
Regulatory Affairs,
North America
Jennifer Riter
Senior Director, West Analytical Services and Business Operations
CPhI & P-MEC China E-trade Season
March - June 2021